As the sector association of the biotechnology industry, BIO Deutschland has set itself the objective of supporting and promoting the development of an innovative economic sector based on modern biosciences.
The Berlin-based association currently has over 360 members. It is run by a board of ten members consisting of CEOs and managing directors of biotechnology companies. This committee comprehensively represents the various fields in the sector.
The member companies and their experts are organised in working groups and networks that deal with the following topics: bio-IT, big data & e-health, finance and taxation; diagnostics, industrial bioeconomy, industrial cell technology, licences and technical contracts; regulatory matters; innovation and entrepreneurship; German-US cooperation; health policy; technology transfer; and PR. Using a wide range of political initiatives, BIO Deutschland lobbies for improvements to the legal parameters for innovative small and medium-sized enterprises.
BIO Deutschland is Germany’s biotechnology sector representative at the BDI, the voice of the German Industry, and at the European association, EuropaBio, in Brussels. BIO Deutschland also works closely with other biotech organisations in Europe and the USA in order to lobby for the interests of the sector in an internationally coordinated way. The association is also very active in a broad range of events with the aim of providing biotechnology with a platform for discussion and interaction.